1. "Sergio Giralt"
Formats
  1. Meeting Abstract (632)
  2. Journal Article (371)
  3. Research Letter (17)
  4. Review (15)
  5. Guidelines (5)
  6. Editorial (4)
  7. Book Section (3)
  8. Correspondence (3)
Groups
  1. Bone Marrow Transplant (1050)
  2. Center for Hematologic Malignancies (1050)
  3. Department of Medicine (1050)
  4. Hematologic Malignancies, Division of (1050)
  5. Survivorship Research (684)
  6. CTCR Scholars (539)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (421)
  3. Sean Devlin (372)
  4. Gunjan Shah (297)
  5. Michael Scordo (266)
  6. Heather Landau (253)

More People

Years
  1. 2025 (9)
  2. 2024 (55)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (304)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (384)
  2. American Society of Hematology (336)
  3. Nature Publishing Group (108)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1050)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of cyclosporine-a (CSA) levels supports new dosing guidelines in adult double unit cord blood transplant (dCBT) recipients to optimize immunosuppression early post-transplant
    Meeting Abstract

    Bhatt, V.; Lin, A.; Beyer, K.; Proli, A. J.; Yoo, Y.; Lauer, E.; Giralt, S. A.; Ponce, D. M.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Prospective evaluation of cord blood (CB) and haplo-identical (haplo) donor availability reveals compromised donor access for both CB and haplo grafts in minority patients
    Meeting Abstract

    Kosuri, S.; Wolff, T.; Lauer, E.; Byam, C.; Yoo, Y.; Davis, E.; Paulson, J.; Sideroff, M.; Wells, D. S.; Perales, M. A.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Stool PCR for Clostridium difficile Toxin B is frequently detected at the first stool assay in the immediate peri-transplant period in allogeneic hematopoietic stem cell transplant (HSCT) recipients
    Meeting Abstract

    Bekele, S.; Patterson, E.; Kelly, S.; Featherstone, C.; Giralt, S. A.; Perales, M. A.; Robilotti, E.; Jenq, R.; Ponce, D. M.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted (TCD) grafts for allogeneic hematopoietic cell transplantation (Allo-HSCT) is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Dierov, D.; Herman, D.; Mosesso, K.; Nieves, J.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells (HPC) does not improve neutrophil recovery or survival in patients undergoing allogeneic
    Meeting Abstract

    Kosuri, S.; Gyurkocza, B.; Devlin, S. M.; Maloy, M.; Ciolino, C.; Borrill, T.; Jakubowski, A. A.; Papadopoulos, E.; Castro-Malaspina, H.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Impact of busulfan exposure on transplant outcomes for patients with advanced myelodysplastic syndrome undergoing CD34 selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Proli, A. J.; Tamari, R.; Zheng, J.; Jakubowski, A. A.; Papadopoulos, E.; Ponce, D. M.; Devlin, S. M.; Sauter, C. S.; Perales, M. A.; Young, J. W.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Outcomes of diffuse large B-cell lymphoma (DLBCL) patients progressing after autologous hematopoietic stem cell transplant
    Meeting Abstract

    Gil-Cupello, M.; Shah, G. L.; Maloy, M. A.; Goldman, D. A.; Devlin, S. M.; Matasar, M. J.; Giralt, S. A.; Sauter, C. S.; Moskowitz, C. H.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Low dose unfractionated heparin (UFH) prophylaxis is a feasible strategy for the prevention of hepatic sinusoidal obstruction syndrome (SOS) after myeloablative adult allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Bhatt, V.; Palazzo, M.; Kilroy, K.; Hilden, P.; Devlin, S. M.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Chung, D. J.; Dahi, P.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CC-486 (oral azacitidine) maintenance therapy is well tolerated after allogeneic hematopoietic stem cell transplantation (AlloHSCT) in patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)
    Meeting Abstract

    de Lima, M.; Oran, B.; Papadopoulos, E. B.; Scott, B. L.; William, B. M.; Giralt, S. A.; Champlin, R. E.; Hetzer, J.; Tosolini, A.; Laille, E.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save